Media archive English
Research investment — September 24, 2002
The dated route carries strong link metrics. Anchor evidence elsewhere in the same export set repeatedly references pharmaceutical R&D spending and a proposed industry 'new deal', so research investment is the most defensible topic reconstruction.
Explore a related topic01
What this page covers
Debates about pharmaceutical R&D investment usually connect company commitments, the policy environment, domestic research capacity and expectations for public value.
- Define which spending qualifies as R&D
- Separate announced commitments from realized spending
- Consider public, academic and private research together
- Measure outcomes over an appropriate time horizon
02
How to use this archive entry
The exact wording and any historic dollar figure remain unknown and are not reproduced.